Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Secretoglobin family 2B member 2 is a small, secreted protein comprising 96 amino acids, encoded by the SCGB2B2 gene (HGNC:27616, NCBI Gene:284402, UniProt:Q4G0G5)[1][4][6]. It belongs to the **secretoglobin** superfamily, which is expressed mainly in mammalian tissues and is known for involvement in immune modulation, tissue repair, and possibly tumorigenesis[2]. However, the specific roles, tissue localization, and interacting partners of SCGB2B2 remain largely uncharacterized in the scientific literature[1][2]. It is phylogenetically related to other secretoglobins and may share general features such as roles in secretion and dimer formation but has not been directly implicated as a receptor, enzyme, or transporter nor as a drug target. No clinical biomarkers or safety concerns have been reported for SCGB2B2[1][2][6].
None (not recognized as a therapeutic drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Secretoglobin family 2B member 2 (SCGB2B2).